IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
101.74%
Total 13F principal
$109,604,000
Principal change
+$2,000,000
Total reported market value
$111,251,427
Number of holders
21
Value change
+$2,037,726
Number of buys
4
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q1 2022

As of 31 Mar 2022, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $109,604,000 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, HBK INVESTMENTS L P, DeepCurrents Investment Group LLC, CSS LLC/IL, TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., Verition Fund Management LLC, JPMORGAN CHASE & CO, CALAMOS ADVISORS LLC, and PALISADE CAPITAL MANAGEMENT LLC/NJ. This page lists 21 institutional bondholders reporting positions for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.